158 related articles for article (PubMed ID: 34911496)
1. The opposing action of stromal cell proenkephalin and stem cell transcription factors in prostate cancer differentiation.
Liu AY
BMC Cancer; 2021 Dec; 21(1):1335. PubMed ID: 34911496
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer research: tools, cell types, and molecular targets.
Liu AY
Front Oncol; 2024; 14():1321694. PubMed ID: 38595814
[TBL] [Abstract][Full Text] [Related]
3. Lineage relationship between prostate adenocarcinoma and small cell carcinoma.
Kanan AD; Corey E; Vêncio RZN; Ishwar A; Liu AY
BMC Cancer; 2019 May; 19(1):518. PubMed ID: 31146720
[TBL] [Abstract][Full Text] [Related]
4. Conversion of Prostate Adenocarcinoma to Small Cell Carcinoma-Like by Reprogramming.
Borges GT; Vêncio EF; Quek SI; Chen A; Salvanha DM; Vêncio RZ; Nguyen HM; Vessella RL; Cavanaugh C; Ware CB; Troisch P; Liu AY
J Cell Physiol; 2016 Sep; 231(9):2040-7. PubMed ID: 26773436
[TBL] [Abstract][Full Text] [Related]
5. Reprogramming of prostate cancer-associated stromal cells to embryonic stem-like.
Vêncio EF; Nelson AM; Cavanaugh C; Ware CB; Milller DG; Garcia JC; Vêncio RZ; Loprieno MA; Liu AY
Prostate; 2012 Sep; 72(13):1453-63. PubMed ID: 22314551
[TBL] [Abstract][Full Text] [Related]
6. Expression of pluripotent stem cell reprogramming factors by prostate tumor initiating cells.
Bae KM; Su Z; Frye C; McClellan S; Allan RW; Andrejewski JT; Kelley V; Jorgensen M; Steindler DA; Vieweg J; Siemann DW
J Urol; 2010 May; 183(5):2045-53. PubMed ID: 20303530
[TBL] [Abstract][Full Text] [Related]
7. Stromal mesenchyme cell genes of the human prostate and bladder.
Goo YA; Goodlett DR; Pascal LE; Worthington KD; Vessella RL; True LD; Liu AY
BMC Urol; 2005 Dec; 5():17. PubMed ID: 16343351
[TBL] [Abstract][Full Text] [Related]
8. Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway.
Corominas-Faja B; Cufí S; Oliveras-Ferraros C; Cuyàs E; López-Bonet E; Lupu R; Alarcón T; Vellon L; Iglesias JM; Leis O; Martín ÁG; Vazquez-Martin A; Menendez JA
Cell Cycle; 2013 Sep; 12(18):3109-24. PubMed ID: 23974095
[TBL] [Abstract][Full Text] [Related]
9. Two-stage induced differentiation of OCT4+/Nanog+ stem-like cells in lung adenocarcinoma.
Li R; Huang J; Ma M; Lou Y; Zhang Y; Wu L; Chang DW; Zhao P; Dong Q; Wu X; Han B
Oncotarget; 2016 Oct; 7(42):68360-68370. PubMed ID: 27588392
[TBL] [Abstract][Full Text] [Related]
10. Reprogramming Prostate Cancer Cells into Induced Pluripotent Stem Cells: a Promising Model of Prostate Cancer Stem Cell Research.
Zhang Y; Chen B; Xu P; Liu C; Huang P
Cell Reprogram; 2020 Oct; 22(5):262-268. PubMed ID: 32816532
[TBL] [Abstract][Full Text] [Related]
11. Terminal differentiation and loss of tumorigenicity of human cancers via pluripotency-based reprogramming.
Zhang X; Cruz FD; Terry M; Remotti F; Matushansky I
Oncogene; 2013 May; 32(18):2249-60, 2260.e1-21. PubMed ID: 22777357
[TBL] [Abstract][Full Text] [Related]
12. Cancer-secreted AGR2 induces programmed cell death in normal cells.
Vitello EA; Quek SI; Kincaid H; Fuchs T; Crichton DJ; Troisch P; Liu AY
Oncotarget; 2016 Aug; 7(31):49425-49434. PubMed ID: 27283903
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional regulation of Rex1 (zfp42) in normal prostate epithelial cells and prostate cancer cells.
Lee MY; Lu A; Gudas LJ
J Cell Physiol; 2010 Jul; 224(1):17-27. PubMed ID: 20232320
[TBL] [Abstract][Full Text] [Related]
14. Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells.
Kong D; Banerjee S; Ahmad A; Li Y; Wang Z; Sethi S; Sarkar FH
PLoS One; 2010 Aug; 5(8):e12445. PubMed ID: 20805998
[TBL] [Abstract][Full Text] [Related]
15. Partial inhibition of differentiation associated with elevated protein levels of pluripotency factors in mouse embryonic stem cells expressing exogenous EGAM1N homeoprotein.
Sato S; Nakazawa M; Kihara Y; Kubo Y; Sato Y; Kikuchi T; Nonaka A; Sasaki A; Iwashita J; Murata J; Hosaka M; Kobayashi M
J Biosci Bioeng; 2015 Nov; 120(5):562-9. PubMed ID: 25817697
[TBL] [Abstract][Full Text] [Related]
16. Generation of tumor-initiating cells by exogenous delivery of OCT4 transcription factor.
Beltran AS; Rivenbark AG; Richardson BT; Yuan X; Quian H; Hunt JP; Zimmerman E; Graves LM; Blancafort P
Breast Cancer Res; 2011 Sep; 13(5):R94. PubMed ID: 21952072
[TBL] [Abstract][Full Text] [Related]
17. Silencing of core transcription factors in human EC cells highlights the importance of autocrine FGF signaling for self-renewal.
Greber B; Lehrach H; Adjaye J
BMC Dev Biol; 2007 May; 7():46. PubMed ID: 17506876
[TBL] [Abstract][Full Text] [Related]
18. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma.
Bourguignon LY; Wong G; Earle C; Chen L
J Biol Chem; 2012 Sep; 287(39):32800-24. PubMed ID: 22847005
[TBL] [Abstract][Full Text] [Related]
19. Tip110 Deletion Impaired Embryonic and Stem Cell Development Involving Downregulation of Stem Cell Factors Nanog, Oct4, and Sox2.
Whitmill A; Liu Y; Timani KA; Niu Y; He JJ
Stem Cells; 2017 Jul; 35(7):1674-1686. PubMed ID: 28436127
[TBL] [Abstract][Full Text] [Related]
20. Targeting LA7 breast cancer stem cells of rat through repressing the genes of stemness-related transcription factors using three different biological fluids.
Pourbagher R; Akhavan-Niaki H; Jorsaraei SGA; Fattahi S; Sabour D; Zabihi E; Abedian Z; Ghasemi M; Golpour M; Mostafazadeh A
Gene; 2020 Apr; 734():144381. PubMed ID: 31978510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
